Â¥
27.40
Jul 2
Business Description
Jafron Biomedical Co Ltd
ISIN : CNE100002995
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.74 | |||||
Equity-to-Asset | 0.55 | |||||
Debt-to-Equity | 0.56 | |||||
Debt-to-EBITDA | 2.62 | |||||
Interest Coverage | 11.03 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 6.82 | |||||
Beneish M-Score | -3.59 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.4 | |||||
3-Year EBITDA Growth Rate | -12.3 | |||||
3-Year EPS without NRI Growth Rate | -19.6 | |||||
3-Year FCF Growth Rate | 5.7 | |||||
3-Year Book Growth Rate | 3.5 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.99 | |||||
9-Day RSI | 47.68 | |||||
14-Day RSI | 49.05 | |||||
6-1 Month Momentum % | 24.23 | |||||
12-1 Month Momentum % | 18.98 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.99 | |||||
Quick Ratio | 2.73 | |||||
Cash Ratio | 2.61 | |||||
Days Inventory | 303.79 | |||||
Days Sales Outstanding | 21 | |||||
Days Payable | 123.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.43 | |||||
Dividend Payout Ratio | 1.01 | |||||
3-Year Dividend Growth Rate | 12.2 | |||||
Forward Dividend Yield % | 1.43 | |||||
5-Year Yield-on-Cost % | 5.91 | |||||
3-Year Average Share Buyback Ratio | -0.4 | |||||
Shareholder Yield % | -0.83 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 79.44 | |||||
Operating Margin % | 30.78 | |||||
Net Margin % | 25.06 | |||||
FCF Margin % | 41.87 | |||||
ROE % | 15.9 | |||||
ROA % | 9.21 | |||||
ROIC % | 20.02 | |||||
ROC (Joel Greenblatt) % | 36.96 | |||||
ROCE % | 14.42 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 42.35 | |||||
PE Ratio without NRI | 41.2 | |||||
Shiller PE Ratio | 36.53 | |||||
Price-to-Owner-Earnings | 112.76 | |||||
PEG Ratio | 4 | |||||
PS Ratio | 10.57 | |||||
PB Ratio | 6.85 | |||||
Price-to-Tangible-Book | 7.1 | |||||
Price-to-Free-Cash-Flow | 25.21 | |||||
Price-to-Operating-Cash-Flow | 18.62 | |||||
EV-to-EBIT | 30.93 | |||||
EV-to-EBITDA | 30.93 | |||||
EV-to-Revenue | 10.16 | |||||
EV-to-FCF | 23.54 | |||||
Price-to-Projected-FCF | 2.25 | |||||
Price-to-DCF (Earnings Based) | 1.34 | |||||
Price-to-DCF (FCF Based) | 0.81 | |||||
Price-to-Graham-Number | 3.61 | |||||
Price-to-Net-Current-Asset-Value | 22.64 | |||||
Price-to-Net-Cash | 42.81 | |||||
Earnings Yield (Greenblatt) % | 3.23 | |||||
FCF Yield % | 3.96 | |||||
Forward Rate of Return (Yacktman) % | 4.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Jafron Biomedical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 2,094.127 | ||
EPS (TTM) (Â¥) | 0.647 | ||
Beta | 1.39 | ||
Volatility % | 38.88 | ||
14-Day RSI | 49.05 | ||
14-Day ATR (Â¥) | 0.865499 | ||
20-Day SMA (Â¥) | 27.5955 | ||
12-1 Month Momentum % | 18.98 | ||
52-Week Range (Â¥) | 15.88 - 30.65 | ||
Shares Outstanding (Mil) | 807.56 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Jafron Biomedical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Jafron Biomedical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Jafron Biomedical Co Ltd Frequently Asked Questions
What is Jafron Biomedical Co Ltd(SZSE:300529)'s stock price today?
When is next earnings date of Jafron Biomedical Co Ltd(SZSE:300529)?
Does Jafron Biomedical Co Ltd(SZSE:300529) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |